Treatment for Puberty Disruption

There is no cure for congenital hypogonadotropic hypogonadism (CHH) or Kallmann Syndrome (KS), but personalized, age-appropriate treatments can help develop the outward signs of puberty.
A black arrow pointed downwards.Text that is rotating in a circle that says "Scroll Down".
An illustration showing three health care providers standing together of what appears to be a white male on the left wearing blue scrubs, a black woman in the middle wearing a white coat and blue scrubs underneath, and a brown woman on the right wearing green scrubs.
The gender symbol that represents females.
Treatment for females: Low dose estrogen
Low dose estrogen—in the form of patches or pills—is common and can help with:
  • Muscle Growth
  • Breast development
  • Uterine development
  • Sex drive (libido)
  • Development of feminine figure
  • Increased bone density
  • Combined with progesterone, regular period bleeding (menstruation), but not fertility
The gender symbol that represents males.
Treatment for males: Testosterone
Testosterone—in the form of injections or a gel that is applied to the skin—is the most common treatment and can help with:
  • Muscle Growth
  • Deeperning of the voice
  • Beard growth
  • Penis growth
  • Increased bone density
  • Sex drive (libido)
  • Sexual function, but not fertility
To maximize treatment results for CHH/KS, gradual dose adjustment is important and should be determined based on individual age and tolerability to treatment. It is important to maintain treatment over time as instructed by a healthcare provider.
Fertility Treatment (aka, Gonadotropic Therapy)
Infertility caused by CHH/KS is treatable and most people can become fertile with specialized hormone therapy.
Specialized treatment may mean:
  • Hormone injections several times each week, OR
  • Wearing a portable GnRH pump
  • Care from experienced specialists, such as a reproductive endocrinologist
  • Assisted fertility, such as in vitro fertilization (IVF)
An illustration of four silhouettes. Three of four are colored in blue.
Overall, 3 out of 4 people (75%) are successful at achieving fertility following treatment for CHH/KS-induced infertility.
Fertility Treatment (aka, Gonadotropic Therapy)
Although testosterone and estrogen are not vital hormones for survival, treating CHH/KS can help improve overall health, sexual function, and quality of life.
Left untreated, the lack of testosterone and estrogen can cause health problems, such as:
  • Increased risk for low bone density (osteoporosis)
  • Osteoporosis means that the bones are weak and there is a higher-than-normal risk for fractures. If CHH/KS is not treated, osteoporosis can affect a person at any age. Some people with CHH/KS need extra treatment for osteoporosis. ‍
  • In males, a higher risk of metabolic problems such as pre-diabetes or diabetes
  • Decreased sexual function and desire
  • Fatigue and depression
An illustration of 10 silhouettes. The first of the 10 is colored in blue.
About 1 in 10 people with CHH/KS recover after treatment.
This is called a "reversal" and means they can produce normal hormone levels. The reasons for this are not understood and it is impossible to predict who will have such a reversal. This recovery does not always last, so it is important to be followed closely by a healthcare provider.
Before, during, and after treatment for CHH/KS, it is important to be managed closely by a healthcare provider.
Find tools to help manage CHH/KS
Find more information about available treatments

Hear from us

Please complete the fields and we’ll be in touch with updates as we grow this site
Text that is rotating in circle that says "Hear from us".A black arrow pointed downwards.
I am a (check all that apply)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.